Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 months ago

Possible Interaction: Aspartic Acid and Dopamine


Aspartic Acid

Research Papers that Mention the Interaction

220 Fig. 1 Dopamine acring at D I receprors in rhe prefrontal cortex (PFe) produces an inverted U dose response where by eit her roo lin le or roo mu ch D I recepro r stimularion impairs neuro nal or cognitive func rion.
Journal of the American Academy of Child and Adolescent Psychiatry  •  1999  |  View Paper
5 We report herein, using human tissues, that the density of D 2 is underestimated by radioactive raclopride in the presence of dopamine.
Archives of general psychiatry  •  1990  |  View Paper
In the presence of magnesium, L-glutamate, D ,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole-4-propionate (AMPA) and kainate, but not N-methyl-D-aspartate (NMDA) and 1-aminocyclopentane-1S,3R-dicarboxylate (t-ACPD), stimulated the release of [3H]dopamine , in a dose-dependent manner.
Neurochemistry International  •  1994  |  View Paper
Nemonapride, D ,L-sulpiride, and remoxipride significantly reduced the number of spontaneously active dopamine neurones in the ventral tegmental area, indicating an antipsychotic potential, while raclopride and zacopride induced but minor effects.
European journal of pharmacology  •  1993  |  View Paper
dopamine release evoked by burst stimulation (20 … dose-dependently decreased by D ,L-apomorphine (25-800 micrograms/kg, s.c.) or by quinpirole (50 micrograms/kg, s.c.) while the opposite …/kg-0.5 mg/kg, s.c.) or with D,L-sulpiride (2-200 mg/kg, s.c.).
Neuroscience  •  1991  |  View Paper
The stimulatory effect of dopamine (1 mumol/l) was blocked in a stereospecific manner by the active ( D ) but not by the inactive (L) isomers of the dopamine antagonist butaclamol.
The Journal of endocrinology  •  1987  |  View Paper